← All stocks

Dianthus Therapeutics, Inc. /DE/

DNTH Scheduled selling only

CIK 0001690585 #1220 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$2.79M

$0.00 on a plan · $2.79M straight out of an exercise

Sold at will

$0.00

0 of 4 sales

Net

−$2.79M

$0.00 against sales at will

By person

9 insiders · 4 transactions

11.0×

Marino Garcia holds 11.0 times base salary in stock. $6.97M of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marino Garcia last reported holding, valued at $106.74, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Randhawa Simrat

EVP, Head of R&D

—

$2.46M (3) scheduled

−$2.46M

4,000

0.0072%

$426.96K

0.0%

Read Simon

Director

—

$326.55K (1) scheduled

−$326.55K

0.0000%

$0.00

—

Garcia Marino

CEO AND PRESIDENT

—

65,292

0.1167%

$6.97M

—

Veness Adam M

SVP, General Counsel and Sec.

—

15,000

0.0268%

$1.60M

—

Fairmount Funds Management LLC entity

Director

—

0.0000%

$0.00

−100.0%

McGeorge Anne

Director

—

0.0000%

$0.00

—

Savitz Ryan

EVP, CFO & CBO

—

0.0000%

$0.00

—

Soteropoulos Paula

Director

—

0.0000%

$0.00

—

CARR EDWARD

CHIEF ACCOUNTING OFFICER

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Randhawa Simrat

1 Sep 2026

EVP, Head of R&D

Sold after exercise

13,309

$106.74

$1.42M

Randhawa Simrat

1 Sep 2026

EVP, Head of R&D

Sold after exercise

7,215

$106.25

$766.59K

Randhawa Simrat

1 Sep 2026

EVP, Head of R&D

Sold after exercise

2,600

$105.19

$273.49K

Read Simon

19 Aug 2026

Director

Sold after exercise

2,778

$117.55

$326.55K

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 4

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 25,902

History held since 27 Jun 2018